Validea Detailed Fundamental Analysis

Johnson & Johnson (JNJ) has received an 88% rating from Validea's P/B Growth Investor model, based on Partha Mohanram's academically-derived strategy, which identifies low book-to-market stocks with sustained growth potential and has demonstrated market outperformance. This high score indicates significant interest in the large-cap Biotechnology & Drugs stock as a strong growth prospect, with JNJ passing nearly all fundamental criteria of the rigorous model.

Analysis

Johnson & Johnson (JNJ) has been identified as a strong candidate by Validea's P/B Growth Investor model, achieving an 88% rating. This academically-derived strategy, developed by Partha Mohanram, specifically targets low book-to-market stocks that exhibit fundamental characteristics associated with sustained future growth. The 88% score indicates significant interest, falling just short of the 90% threshold for 'strong interest'. JNJ, a large-cap stock in the Biotechnology & Drugs industry, demonstrated broad-based fundamental health by passing eight of the model's nine criteria. These successful tests include key metrics such as Return on Assets (ROA), Cash Flow From Operations to Assets, and stability indicators like ROA and sales variance. However, the analysis revealed a single point of failure: the company did not meet the model's threshold for Research and Development to Assets, a potentially significant detail for a firm reliant on innovation within its sector.

Key Decisions for Investors

• Given the high 88% score from a historically outperforming growth model, investors with a factor-based, growth-oriented mandate should view this as a strong positive signal for JNJ's fundamental profile.
• The specific failure on the 'Research and Development to Assets' metric warrants further due diligence; investors should investigate JNJ's R&D pipeline and capital allocation strategy to assess if this constitutes a meaningful risk to long-term growth.
• As the positive rating is derived from a specific 'low book-to-market' growth screen, investors should consider if this quantitative approach aligns with their own investment philosophy before heavily weighting this single analysis.